A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2017
At a glance
- Drugs GSK 1292263; Rosuvastatin; Simvastatin
- Indications Lipid metabolism disorders; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 30 Aug 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 30 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.